DIABETES MELLITUS, TYPE 1
Clinical trials for DIABETES MELLITUS, TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new DIABETES MELLITUS, TYPE 1 trials appear
Sign up with your email to follow new studies for DIABETES MELLITUS, TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mental health help for diabetes patients shows promise
Disease control OngoingThis study is testing whether adding mental health support to regular diabetes care helps adults with type 1 diabetes. Participants will complete surveys about their mood and health habits every six months. Some will also work with a mental health coach by phone or video to set p…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
Family teamwork tackles diabetes and weight
Disease control OngoingThis study is testing a 6-month family coaching program to see if it can help manage weight and improve health in young people with type 1 diabetes who are also overweight or obese. The program includes both the child and at least one overweight parent, using a mix of in-person a…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
Tech and human help aim to bridge gaps in diabetes care
Disease control OngoingThis study is testing whether providing a continuous glucose monitor and a dedicated Patient Navigator can help people with type 1 diabetes who have struggled with severe complications or high blood sugar. It aims to see if this combination of technology and personal support impr…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
Could new pills slow down type 1 diabetes?
Disease control OngoingThis study is testing whether two oral medications can help preserve the body's remaining ability to produce insulin in people recently diagnosed with type 1 diabetes. It involves 78 participants aged 12-35 who were diagnosed within the last 100 days. Participants will take one o…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New tech aims to tame dangerous blood sugar in High-Risk dialysis patients
Disease control OngoingThis study is testing if using a continuous glucose monitor (CGM) can help diabetic patients on kidney dialysis manage their blood sugar better than the standard method of finger-prick checks. It will involve 96 participants who will be assigned to either use a CGM continuously, …
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: NA • Sponsor: Bo Feldt-Rasmussen • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Early test of a 'Living Bandage' for diabetes cells
Disease control OngoingThis is an early safety study testing a new device called ENC-201-CED. It is designed to protect insulin-producing cells (islets) after they are transplanted under the skin in people with Type 1 diabetes. The main goal is to see if the device is safe and well-tolerated in 10 part…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE1 • Sponsor: Encellin • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Could a diabetes drug fix damaged blood vessels?
Disease control TerminatedThis study is testing if a medication called dulaglutide can improve the health of tiny blood vessels in the muscles of adults with type 1 diabetes. Researchers believe better blood flow might help the body use insulin more effectively. The trial is currently suspended and was co…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists track kids for years after promising diabetes drug trial
Disease control OngoingThis study follows children and teenagers who recently received a drug called teplizumab for type 1 diabetes. The goal is to monitor their health for any long-term side effects over the next 3.5 years. No new treatment is given; researchers are just observing participants who fin…
Matched conditions: DIABETES MELLITUS, TYPE 1
Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Transplant trial aims to free brittle diabetes patients from insulin shots
Disease control OngoingThis study is testing the safety of transplanting insulin-producing cells from donors into adults with severe, unstable type 1 diabetes. The goal is to see if this procedure can help control blood sugar levels, reduce or eliminate the need for insulin injections, and prevent dang…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
Drug tested in youngest ever type 1 diabetes patients
Disease control OngoingThis study is testing the safety and how the body processes teplizumab in very young children (under 8 years old) who have early signs of type 1 diabetes but haven't developed full symptoms yet. About 20 children will receive the drug through daily IV infusions for 14 days, and r…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
Implanted cells aim to tame dangerous blood sugar drops
Disease control TerminatedThis early-stage study aimed to test the safety and effectiveness of implanting clusters of pancreatic cells (SR-02) into the abdomen of adults with Type 1 diabetes who experience severe low blood sugar. The goal was to see if the implanted cells could help the body produce its o…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE1, PHASE2 • Sponsor: Seraxis • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
Teens mentor teens to tackle diabetes tech
Disease control OngoingThis study is testing a new 6-month peer mentorship program designed to help teenagers with type 1 diabetes use their continuous glucose monitors (CGMs) more regularly. It compares the program, which includes monthly meetings with a mentor family and a health coach, to standard m…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: NA • Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Four-Drug cocktail aims to halt type 1 diabetes in its tracks
Disease control TerminatedThis study aimed to test whether a combination of four drugs could help people recently diagnosed with type 1 diabetes keep making their own insulin. The goal was to see if this treatment could protect the body's remaining insulin-producing cells better than a placebo. The trial …
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE1, PHASE2 • Sponsor: Camillo Ricordi and Jay Skyler • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Common diabetes drug may shield pregnant women from dangerous blood pressure spike
Prevention OngoingThis study is testing if adding the common diabetes medication metformin to usual care can help prevent dangerous high blood pressure disorders during pregnancy in women with type 1 diabetes. Researchers are enrolling 60 pregnant women with type 1 diabetes to take either metformi…
Matched conditions: DIABETES MELLITUS, TYPE 1
Phase: PHASE4 • Sponsor: Maisa N. Feghali, MD • Aim: Prevention
Last updated Mar 16, 2026 15:27 UTC
-
Diabetes patients rate their new injection device
Symptom relief OngoingThis study is collecting feedback from people already using the DuraTouch insulin injection device in their daily lives. About 125 people with type 1 or type 2 diabetes will rate how easy, convenient, and satisfying the device is to use over 12 weeks. The goal is to understand th…
Matched conditions: DIABETES MELLITUS, TYPE 1
Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Mar 24, 2026 12:06 UTC
-
Scientists investigate how type 1 diabetes affects growing older
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how people with type 1 diabetes experience aging compared to people without the condition. Researchers will observe 400 participants over 65 years old to measure their physical, mental, and overall health. The goal is to identify what factors help pe…
Matched conditions: DIABETES MELLITUS, TYPE 1
Sponsor: Helsinki University Central Hospital • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC